MOESM8 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

MOESM8 of A high-throughput screen of inactive X chromosome reactivation identifies the enhancement of DNA demethylation by 5-aza-2′-dC upon inhibition of ribonucleotide reductase

Alissa Minkovsky (3400172)
Anna Sahakyan (106588)
Giancarlo Bonora (3400169)
Robert Damoiseaux (326975)
Elizabeth Dimitrova (3400166)
Liudmilla Rubbi (749064)
Matteo Pellegrini (2078)
Caius Radu (3400175)
Kathrin Plath (128265)

October 2015

Additional file 8: Figure S7. Analysis of autosomal DNA methylation in MEFs treated with combination...

Research Article Comparative (Computational) Analysis of the DNA Methylation Status of Trinucleotide Repeat Expansion Diseases

Mohammadmersad Ghorbani
Simon J. E. Taylor
Mark A. Pook
Annette Payne

August 2016

Additional file 6: Table S5. of Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome

Sarah Brasa (226861)
Arne Mueller (3518105)
SĂŠbastien Jacquemont (3518102)
Florian Hahne (14246)
Izabela Rozenberg (214521)
Thomas Peters (147287)
Yunsheng He (3518108)
Christine McCormack (3518111)
Fabrizio Gasparini (3011970)
Salah-Dine Chibout (370640)
Olivier Grenet (106357)
Jonathan Moggs (147210)
Baltazar Gomez-Mancilla (3518099)
RĂŠmi Terranova (3518096)

February 2016

This table summarizes linear regression analyses (p value, RSq, R) for the indicated molecular assay...

MOESM7 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Elisabetta Tabolacci (268801)
Giorgia Mancano (434928)
Stella Lanni (434925)
Federica Palumbo (3569810)
Martina Goracci (434926)
Fabrizio FerrĂ¨ (3459266)
Manuela Helmer-Citterich (10228)
Giovanni Neri (109017)

March 2016

Additional file 7: Table S4. List of DMRs and their chromosome position in the comparison between WT...

MOESM1 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Elisabetta Tabolacci (268801)
Giorgia Mancano (434928)
Stella Lanni (434925)
Federica Palumbo (3569810)
Martina Goracci (434926)
Fabrizio FerrĂ¨ (3459266)
Manuela Helmer-Citterich (10228)
Giovanni Neri (109017)

March 2016

Additional file 1: Figure S1. Bisulphite sequencing of the FMR1 methylation boundary after 5-azadC t...

MOESM5 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Elisabetta Tabolacci (268801)
Giorgia Mancano (434928)
Stella Lanni (434925)
Federica Palumbo (3569810)
Martina Goracci (434926)
Fabrizio Ferrè (116771)
Manuela Helmer-Citterich (10228)
Giovanni Neri (109017)

March 2016

Additional file 5: Figure S2. Distribution curve of beta values for each of nine different samples. ...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, E
Mancano, G
Lanni, S
Palumbo, F
Goracci, M
Ferre, F
HELMER CITTERICH, MANUELA
Neri, G.

March 2016

Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5' UTR of the FMR1 gene ...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, E
Mancano, G
Lanni, S
Palumbo, F
Goracci, M
Ferre, F
HELMER CITTERICH, MANUELA
Neri, G.

March 2016

Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5' UTR of the FMR1 gene ...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, E
Mancano, G
Lanni, S
Palumbo, F
Goracci, M
Ferre, F
HELMER CITTERICH, MANUELA
Neri, G.

March 2016

Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5' UTR of the FMR1 gene ...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, E
Mancano, G
Lanni, S
Palumbo, F
Goracci, M
Ferre, F
HELMER CITTERICH, MANUELA
Neri, G.

March 2016

Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5' UTR of the FMR1 gene ...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

April 2016

open8noThis work was supported by Telethon Grant (GGP10150), FRAXA Foundation and Italian Associatio...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, Elisabetta (ORCID:0000-0002-4707-2242)
Mancano, Giorgia
Lanni, Stella
Palumbo, Federica
Goracci, Martina
Neri, Giovanni

January 2016

Background: Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5′ UTR of th...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, Elisabetta (ORCID:0000-0002-4707-2242)
Mancano, Giorgia
Lanni, Stella
Palumbo, Federica
Goracci, Martina
Neri, Giovanni

January 2016

Background: Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5′ UTR of th...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, Elisabetta
Mancano, Giorgia
Lanni, Stella
Palumbo, Federica
Goracci, Martina
Helmer Citterich, Manuela
Neri, Giovanni
FERRE', FABRIZIO

January 2016

Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5' UTR of the FMR1 gene ...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, Elisabetta
Mancano, Giorgia
Lanni, Stella
Palumbo, Federica
Goracci, Martina
Helmer Citterich, Manuela
Neri, Giovanni
FERRE', FABRIZIO

January 2016

Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5' UTR of the FMR1 gene ...

MOESM8 of A high-throughput screen of inactive X chromosome reactivation identifies the enhancement of DNA demethylation by 5-aza-2′-dC upon inhibition of ribonucleotide reductase

Alissa Minkovsky (3400172)
Anna Sahakyan (106588)
Giancarlo Bonora (3400169)
Robert Damoiseaux (326975)
Elizabeth Dimitrova (3400166)
Liudmilla Rubbi (749064)
Matteo Pellegrini (2078)
Caius Radu (3400175)
Kathrin Plath (128265)

October 2015

Additional file 8: Figure S7. Analysis of autosomal DNA methylation in MEFs treated with combination...

Research Article Comparative (Computational) Analysis of the DNA Methylation Status of Trinucleotide Repeat Expansion Diseases

Mohammadmersad Ghorbani
Simon J. E. Taylor
Mark A. Pook
Annette Payne

August 2016

Additional file 6: Table S5. of Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome

Sarah Brasa (226861)
Arne Mueller (3518105)
SĂŠbastien Jacquemont (3518102)
Florian Hahne (14246)
Izabela Rozenberg (214521)
Thomas Peters (147287)
Yunsheng He (3518108)
Christine McCormack (3518111)
Fabrizio Gasparini (3011970)
Salah-Dine Chibout (370640)
Olivier Grenet (106357)
Jonathan Moggs (147210)
Baltazar Gomez-Mancilla (3518099)
RĂŠmi Terranova (3518096)

February 2016

This table summarizes linear regression analyses (p value, RSq, R) for the indicated molecular assay...

MOESM7 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Elisabetta Tabolacci (268801)
Giorgia Mancano (434928)
Stella Lanni (434925)
Federica Palumbo (3569810)
Martina Goracci (434926)
Fabrizio FerrĂ¨ (3459266)
Manuela Helmer-Citterich (10228)
Giovanni Neri (109017)

March 2016

Additional file 7: Table S4. List of DMRs and their chromosome position in the comparison between WT...

MOESM1 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Elisabetta Tabolacci (268801)
Giorgia Mancano (434928)
Stella Lanni (434925)
Federica Palumbo (3569810)
Martina Goracci (434926)
Fabrizio FerrĂ¨ (3459266)
Manuela Helmer-Citterich (10228)
Giovanni Neri (109017)

March 2016

Additional file 1: Figure S1. Bisulphite sequencing of the FMR1 methylation boundary after 5-azadC t...

MOESM5 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Elisabetta Tabolacci (268801)
Giorgia Mancano (434928)
Stella Lanni (434925)
Federica Palumbo (3569810)
Martina Goracci (434926)
Fabrizio Ferrè (116771)
Manuela Helmer-Citterich (10228)
Giovanni Neri (109017)

March 2016

Additional file 5: Figure S2. Distribution curve of beta values for each of nine different samples. ...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, E
Mancano, G
Lanni, S
Palumbo, F
Goracci, M
Ferre, F
HELMER CITTERICH, MANUELA
Neri, G.

March 2016

Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5' UTR of the FMR1 gene ...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, E
Mancano, G
Lanni, S
Palumbo, F
Goracci, M
Ferre, F
HELMER CITTERICH, MANUELA
Neri, G.

March 2016

Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5' UTR of the FMR1 gene ...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, E
Mancano, G
Lanni, S
Palumbo, F
Goracci, M
Ferre, F
HELMER CITTERICH, MANUELA
Neri, G.

March 2016

Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5' UTR of the FMR1 gene ...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, E
Mancano, G
Lanni, S
Palumbo, F
Goracci, M
Ferre, F
HELMER CITTERICH, MANUELA
Neri, G.

March 2016

Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5' UTR of the FMR1 gene ...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

April 2016

open8noThis work was supported by Telethon Grant (GGP10150), FRAXA Foundation and Italian Associatio...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, Elisabetta (ORCID:0000-0002-4707-2242)
Mancano, Giorgia
Lanni, Stella
Palumbo, Federica
Goracci, Martina
Neri, Giovanni

January 2016

Background: Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5′ UTR of th...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, Elisabetta (ORCID:0000-0002-4707-2242)
Mancano, Giorgia
Lanni, Stella
Palumbo, Federica
Goracci, Martina
Neri, Giovanni

January 2016

Background: Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5′ UTR of th...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, Elisabetta
Mancano, Giorgia
Lanni, Stella
Palumbo, Federica
Goracci, Martina
Helmer Citterich, Manuela
Neri, Giovanni
FERRE', FABRIZIO

January 2016

Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5' UTR of the FMR1 gene ...

Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Tabolacci, Elisabetta
Mancano, Giorgia
Lanni, Stella
Palumbo, Federica
Goracci, Martina
Helmer Citterich, Manuela
Neri, Giovanni
FERRE', FABRIZIO

January 2016

Fragile X syndrome (FXS) is caused by CGG expansion over 200 repeats at the 5' UTR of the FMR1 gene ...

MOESM8 of A high-throughput screen of inactive X chromosome reactivation identifies the enhancement of DNA demethylation by 5-aza-2′-dC upon inhibition of ribonucleotide reductase

Alissa Minkovsky (3400172)
Anna Sahakyan (106588)
Giancarlo Bonora (3400169)
Robert Damoiseaux (326975)
Elizabeth Dimitrova (3400166)
Liudmilla Rubbi (749064)
Matteo Pellegrini (2078)
Caius Radu (3400175)
Kathrin Plath (128265)

October 2015

Additional file 8: Figure S7. Analysis of autosomal DNA methylation in MEFs treated with combination...

Research Article Comparative (Computational) Analysis of the DNA Methylation Status of Trinucleotide Repeat Expansion Diseases

Mohammadmersad Ghorbani
Simon J. E. Taylor
Mark A. Pook
Annette Payne

August 2016

Additional file 6: Table S5. of Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome

Sarah Brasa (226861)
Arne Mueller (3518105)
SĂŠbastien Jacquemont (3518102)
Florian Hahne (14246)
Izabela Rozenberg (214521)
Thomas Peters (147287)
Yunsheng He (3518108)
Christine McCormack (3518111)
Fabrizio Gasparini (3011970)
Salah-Dine Chibout (370640)
Olivier Grenet (106357)
Jonathan Moggs (147210)
Baltazar Gomez-Mancilla (3518099)
RĂŠmi Terranova (3518096)

February 2016

This table summarizes linear regression analyses (p value, RSq, R) for the indicated molecular assay...

MOESM8 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Abstract

Extracted data

MOESM8 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Abstract

Extracted data

Related items

Related items